Some established tumor-specific biomarkers, including carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 242, CA724, and serum pepsinogen (SPG), are known to have limitations in the diagnosis of GC 116. The gene discussed is CEACAM5; the disease is neoplasm.